• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

FRAX 骨折概率高通常提示存在骨密度骨质疏松症:对临床实践的影响。

High fracture probability with FRAX usually indicates densitometric osteoporosis: implications for clinical practice.

机构信息

University of Manitoba, Winnipeg, Canada.

出版信息

Osteoporos Int. 2012 Jan;23(1):391-7. doi: 10.1007/s00198-011-1592-3. Epub 2011 Mar 2.

DOI:10.1007/s00198-011-1592-3
PMID:21365460
Abstract

UNLABELLED

Most patients designated as high risk of fracture using fracture risk assessment tool (FRAX) with femoral neck bone mineral density (BMD) (i.e., 10-year major osteoporotic fracture probability exceeding 20% or hip fracture exceeding 3%) have one or more T-scores in the osteoporotic range; conversely, almost no high risk patients have normal T-scores at all bone mineral density measurement sites.

INTRODUCTION

We determined the agreement between a FRAX designation of high risk of fracture [defined as 10-year major osteoporotic fracture probability (≥ 20%) or hip fracture probability (≥ 3%)] and the WHO categorizations of bone mineral density according to T-score.

METHODS

Ten-year FRAX probabilities calculated with femoral neck BMD were derived using both Canadian and US white tools for a large clinical cohort of 36,730 women and 2,873 men age 50 years and older from Manitoba, Canada. Individuals were classified according to FRAX fracture probability and BMD T-scores alone.

RESULTS

Most individuals designated by FRAX as high risk of major osteoporotic fracture had a T-score in the osteoporotic range at one or more BMD measurement sites (85% with Canadian tool and 83% with US white tool). The majority of individuals deemed at high risk of hip fracture had one or more T-scores in the osteoporotic range (66% with Canadian tool and 64% with US white tool). Conversely, there were extremely few individuals (<1%) who were at high risk of major osteoporotic or hip fracture with normal T-scores at all BMD measurement sites.

CONCLUSIONS

A FRAX designation of high risk of fracture is usually associated with a densitometric diagnosis of osteoporosis.

摘要

未加标签

大多数使用股骨颈骨密度(BMD)的骨折风险评估工具(FRAX)被指定为骨折高风险的患者(即 10 年主要骨质疏松性骨折概率超过 20%或髋部骨折超过 3%),其一个或多个骨密度测量部位的 T 评分处于骨质疏松范围内;相反,几乎没有高风险患者的所有骨密度测量部位的 T 评分都正常。

引言

我们确定了 FRAX 骨折高风险的指定(定义为 10 年主要骨质疏松性骨折概率(≥20%)或髋部骨折概率(≥3%))与根据 T 评分的世界卫生组织(WHO)骨密度分类之间的一致性。

方法

使用加拿大和美国的白人工具,从加拿大马尼托巴省的 36730 名女性和 2873 名 50 岁及以上的男性中得出了基于股骨颈 BMD 的 10 年 FRAX 概率。个体根据 FRAX 骨折概率和 BMD T 评分单独进行分类。

结果

大多数被 FRAX 指定为主要骨质疏松性骨折高风险的个体在一个或多个 BMD 测量部位的 T 评分处于骨质疏松范围内(加拿大工具为 85%,美国白人工具为 83%)。大多数被认为髋部骨折高风险的个体在一个或多个骨密度测量部位的 T 评分处于骨质疏松范围内(加拿大工具为 66%,美国白人工具为 64%)。相反,在所有 BMD 测量部位的 T 评分都正常的情况下,属于高风险的主要骨质疏松性或髋部骨折的个体非常少(<1%)。

结论

FRAX 骨折高风险的指定通常与骨质疏松症的密度测定诊断相关。

相似文献

1
High fracture probability with FRAX usually indicates densitometric osteoporosis: implications for clinical practice.FRAX 骨折概率高通常提示存在骨密度骨质疏松症:对临床实践的影响。
Osteoporos Int. 2012 Jan;23(1):391-7. doi: 10.1007/s00198-011-1592-3. Epub 2011 Mar 2.
2
A comparative study of using non-hip bone density inputs with FRAX®.应用 FRAX®时非髋部骨密度输入的对比研究。
Osteoporos Int. 2012 Mar;23(3):853-60. doi: 10.1007/s00198-011-1814-8. Epub 2011 Oct 19.
3
Performance of FRAX in clinical practice according to sex and osteoporosis definitions: the Manitoba BMD registry.FRAX 在临床实践中的表现根据性别和骨质疏松症定义:马尼托巴省 BMD 登记处。
Osteoporos Int. 2018 Mar;29(3):759-767. doi: 10.1007/s00198-018-4415-y. Epub 2018 Feb 5.
4
Construction of a FRAX® model for the assessment of fracture probability in Canada and implications for treatment.构建加拿大骨折风险评估 FRAX®模型及其对治疗的影响。
Osteoporos Int. 2011 Mar;22(3):817-27. doi: 10.1007/s00198-010-1464-2. Epub 2010 Dec 16.
5
Fracture risk assessment without bone density measurement in routine clinical practice.在常规临床实践中不进行骨密度测量的骨折风险评估。
Osteoporos Int. 2012 Jan;23(1):75-85. doi: 10.1007/s00198-011-1747-2. Epub 2011 Aug 18.
6
FRAX for fracture prediction shorter and longer than 10 years: the Manitoba BMD registry.FRAX 用于预测 10 年以上和 10 年以下骨折风险:曼尼托巴省骨密度登记处。
Osteoporos Int. 2017 Sep;28(9):2557-2564. doi: 10.1007/s00198-017-4091-3. Epub 2017 Jun 7.
7
Risk-equivalent T-score adjustment for using lumbar spine trabecular bone score (TBS): the Manitoba BMD registry.使用腰椎骨小梁骨密度(TBS)进行风险等效 T 评分调整:曼尼托巴省 BMD 登记处。
Osteoporos Int. 2018 Mar;29(3):751-758. doi: 10.1007/s00198-018-4405-0. Epub 2018 Feb 1.
8
FRAX provides robust fracture prediction regardless of socioeconomic status.FRAX 提供了强大的骨折预测能力,而不受社会经济地位的影响。
Osteoporos Int. 2014 Jan;25(1):61-9. doi: 10.1007/s00198-013-2525-0. Epub 2013 Nov 5.
9
Impact of spine-hip discordance on fracture risk assessment and treatment qualification in Canada: the Manitoba BMD registry.脊柱-髋部不匹配对加拿大骨折风险评估和治疗资格的影响:马尼托巴省 BMD 登记处。
Arch Osteoporos. 2020 Jun 8;15(1):85. doi: 10.1007/s11657-020-00763-y.
10
Performance of FRAX in a cohort of community-dwelling, ambulatory older men: the Osteoporotic Fractures in Men (MrOS) study.FRAX 在社区居住、活动能力正常的老年男性队列中的表现:男性骨质疏松性骨折研究(MrOS)。
Osteoporos Int. 2013 Apr;24(4):1185-93. doi: 10.1007/s00198-012-2215-3. Epub 2012 Nov 21.

引用本文的文献

1
The 2024 UK clinical guideline for the prevention and treatment of osteoporosis.《2024年英国骨质疏松症防治临床指南》
Arch Osteoporos. 2025 Sep 8;20(1):119. doi: 10.1007/s11657-025-01588-3.
2
Which Patients in the FLS Should Be Prioritised for a DXA Scan Within 12 Weeks?FLS中哪些患者应优先在12周内进行双能X线吸收测定扫描?
J Clin Med. 2025 Aug 8;14(16):5619. doi: 10.3390/jcm14165619.
3
FRAX-derived intervention and assessment thresholds for osteoporosis in ten Middle Eastern countries.基于 FRAX 的骨质疏松干预和评估阈值:十个中东国家的情况。

本文引用的文献

1
Construction of a FRAX® model for the assessment of fracture probability in Canada and implications for treatment.构建加拿大骨折风险评估 FRAX®模型及其对治疗的影响。
Osteoporos Int. 2011 Mar;22(3):817-27. doi: 10.1007/s00198-010-1464-2. Epub 2010 Dec 16.
2
2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary.《2010年加拿大骨质疏松症诊断与管理临床实践指南:摘要》
CMAJ. 2010 Nov 23;182(17):1864-73. doi: 10.1503/cmaj.100771. Epub 2010 Oct 12.
3
American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis.
Arch Osteoporos. 2024 May 23;19(1):41. doi: 10.1007/s11657-024-01397-0.
4
Applications of Artificial Intelligence Methods for the Prediction of Osteoporotic Fractures.人工智能方法在骨质疏松性骨折预测中的应用。
Life (Basel). 2023 Aug 13;13(8):1738. doi: 10.3390/life13081738.
5
Post hip fracture orthogeriatric care-a Canadian position paper addressing challenges in care and strategies to meet quality indicators.髋部骨折后骨科老年病学护理-一份加拿大立场文件,涉及护理方面的挑战和满足质量指标的策略。
Osteoporos Int. 2023 Jun;34(6):1011-1035. doi: 10.1007/s00198-022-06640-3. Epub 2023 Apr 4.
6
An assessment of intervention thresholds for high fracture risk in Chile.智利高骨折风险干预阈值评估。
Arch Osteoporos. 2022 Dec 17;18(1):11. doi: 10.1007/s11657-022-01198-3.
7
UK clinical guideline for the prevention and treatment of osteoporosis.英国临床骨质疏松症预防和治疗指南。
Arch Osteoporos. 2022 Apr 5;17(1):58. doi: 10.1007/s11657-022-01061-5.
8
Safety, Precautions, and Modalities in Cancer Rehabilitation: an Updated Review.癌症康复中的安全性、预防措施及方式:最新综述
Curr Phys Med Rehabil Rep. 2021;9(3):142-153. doi: 10.1007/s40141-021-00312-9. Epub 2021 Jun 19.
9
Comparison of the Osteoporosis Self-Assessment Tool for Asians and the fracture risk assessment tool - FRAX to identify densitometric defined osteoporosis: A discriminatory value analysis in a multi-ethnic female population in Southeast Asia.亚洲人骨质疏松自我评估工具与骨折风险评估工具FRAX用于识别骨密度测定定义的骨质疏松症的比较:东南亚多民族女性人群的鉴别价值分析
Osteoporos Sarcopenia. 2020 Jun;6(2):53-58. doi: 10.1016/j.afos.2020.04.001. Epub 2020 Apr 26.
10
Use of age-dependent FRAX-based intervention thresholds for Singapore.使用基于年龄的 FRAX 干预阈值(新加坡)。
Arch Osteoporos. 2020 Jul 22;15(1):104. doi: 10.1007/s11657-020-00782-9.
美国风湿病学会2010年糖皮质激素性骨质疏松症预防和治疗指南
Arthritis Care Res (Hoboken). 2010 Nov;62(11):1515-26. doi: 10.1002/acr.20295. Epub 2010 Jul 26.
4
A meta-analysis of the efficacy of raloxifene on all clinical and vertebral fractures and its dependency on FRAX.一项关于雷洛昔芬疗效的荟萃分析,包括所有临床和椎体骨折,及其对 FRAX 的依赖性。
Bone. 2010 Oct;47(4):729-35. doi: 10.1016/j.bone.2010.06.009. Epub 2010 Jun 18.
5
Independent clinical validation of a Canadian FRAX tool: fracture prediction and model calibration.加拿大 FRAX 工具的独立临床验证:骨折预测和模型校准。
J Bone Miner Res. 2010 Nov;25(11):2350-8. doi: 10.1002/jbmr.123.
6
The US FRAX filter: avoiding confusion or hindering progress?美国FRAX筛选工具:是造成混淆还是阻碍进展?
Osteoporos Int. 2010 May;21(5):885. doi: 10.1007/s00198-010-1220-7. Epub 2010 Mar 19.
7
Filtering FRAX.筛选FRAX评分。
Osteoporos Int. 2010 Apr;21(4):537-41. doi: 10.1007/s00198-009-1104-x.
8
FRAX assessment of osteoporotic fracture probability in Switzerland.瑞士的 FRAX 评估骨质疏松性骨折概率。
Osteoporos Int. 2010 Mar;21(3):381-9. doi: 10.1007/s00198-009-0975-1. Epub 2009 Jun 11.
9
Bazedoxifene reduces vertebral and clinical fractures in postmenopausal women at high risk assessed with FRAX.巴多昔芬可降低经FRAX评估为高危的绝经后女性的椎体骨折和临床骨折发生率。
Bone. 2009 Jun;44(6):1049-54. doi: 10.1016/j.bone.2009.02.014. Epub 2009 Feb 28.
10
FRAX and its applications to clinical practice.FRAX及其在临床实践中的应用。
Bone. 2009 May;44(5):734-43. doi: 10.1016/j.bone.2009.01.373. Epub 2009 Feb 3.